Description
4-Hydroxytamoxifen (Afimoxifene) is a metabolite of Tamoxifen. Afimoxifene (4-hydroxytamoxifen) is a selective estrogen receptor modulator which is the active metabolite of tamoxifen. Afimoxifene is a transdermal gel formulation and is being developed by Ascend Therapeutics, Inc. under the trademark TamoGel. (Wikipedia)
Top Gene Interactions
Related Pathways
General Information
Mechanism of Action
Target Name | Mechanism of Action | References |
---|---|---|
Estrogen receptor Glucocorticoid receptor Estrogen receptor beta Potassium voltage-gated channel subfamily H member 2 Androgen receptor Metal regulatory transcription factor 1 Progesterone receptor Muscarinic acetylcholine receptor M5 Cytochrome P450 19A1 Nuclear receptor subfamily 1 group I member 2 Sodium-dependent dopamine transporter Sodium-dependent noradrenaline transporter Mu-type opioid receptor Adenosine receptor A1 Adenosine receptor A2a D(2) dopamine receptor D(1A) dopamine receptor 5-hydroxytryptamine receptor 6 Alpha-2C adrenergic receptor 5-hydroxytryptamine receptor 5A Cytochrome P450 2C19 Nuclear factor erythroid 2-related factor 2 |
23611293 |